Alexander K. Arrow Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alexander K. Arrow.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alexander K. Arrow. Alexander K. Arrow is Director in BIOLASE, INC ($BIOL) and President and COO in BIOLASE, INC ($BIOL) and Chief Financial Officer in Atrinsic, Inc. ($ATRN).
Latest Insider Trading Transactions of Alexander K. Arrow
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2021 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | P | 4.98 | 3,000 | 14,940 | 33,000 | |
| May 03 2021 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Buy | P | 2.29 | 1,000 | 2,290 | 120,260 | 119.3 K to 120.3 K (+0.84 %) |
| May 03 2021 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Buy | P | 2.29 | 1,000 | 2,290 | 119,260 | 118.3 K to 119.3 K (+0.85 %) |
| Jul 21 2020 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | A | 1.75 | 124,998 | 218,747 | 124,998 | |
| Feb 26 2020 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | A | 1.75 | 307,497 | 538,120 | 307,497 | |
| Mar 25 2019 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | A | 1.00 | 41,667 | 41,667 | 41,667 | |
| Oct 18 2017 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | A | 1.75 | 75,000 | 131,250 | 75,000 | |
| Jun 21 2016 | ATRN | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Grant | A | 1.25 | 140,000 | 175,000 | 358,260 | 218.3 K to 358.3 K (+64.14 %) |
| May 10 2016 | ATRN | Atrinsic, Inc. | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | P | 1.25 | 18,260 | 22,825 | 118,260 | |
| May 10 2016 | ATRN | Atrinsic, Inc. | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | P | 1.25 | 40,000 | 50,000 | 100,000 | |
| Jul 23 2014 | BIOL | BIOLASE, INC | Arrow Alexander K. | President and COO | Buy | P | 1.92 | 7,812 | 14,999 | 110,387 | 102.6 K to 110.4 K (+7.62 %) |
| Jul 23 2014 | BIOL | BIOLASE, INC | Arrow Alexander K. | President and COO | Buy | P | 1.92 | 7,812 | 14,999 | 110,387 | 102.6 K to 110.4 K (+7.62 %) |
| Jun 11 2013 | BIOL | BIOLASE, INC | Arrow Alexander K. | President and COO | Option Exercise | A | 4.00 | 350,000 | 1,400,000 | 474,500 | |
| Aug 15 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.69 | 400 | 676 | 102,575 | 102.2 K to 102.6 K (+0.39 %) |
| Aug 15 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.68 | 723 | 1,215 | 102,175 | 101.5 K to 102.2 K (+0.71 %) |
| Aug 15 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.67 | 4,800 | 8,016 | 101,452 | 96.7 K to 101.5 K (+4.97 %) |
| Aug 15 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.70 | 377 | 641 | 96,652 | 96.3 K to 96.7 K (+0.39 %) |
| Aug 15 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.73 | 1,237 | 2,140 | 96,275 | 95 K to 96.3 K (+1.30 %) |
| Aug 15 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.72 | 1,100 | 1,892 | 95,038 | 93.9 K to 95 K (+1.17 %) |
| Aug 15 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.71 | 1,363 | 2,331 | 93,998 | 92.6 K to 94 K (+1.47 %) |
| Aug 15 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.83 | 7,500 | 13,725 | 92,575 | 85.1 K to 92.6 K (+8.82 %) |
| Aug 15 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.80 | 9,000 | 16,200 | 85,075 | 76.1 K to 85.1 K (+11.83 %) |
| Aug 15 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.78 | 300 | 534 | 76,075 | 75.8 K to 76.1 K (+0.40 %) |
| Aug 15 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.77 | 7,500 | 13,275 | 75,775 | 68.3 K to 75.8 K (+10.98 %) |
| Aug 15 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.76 | 3,200 | 5,632 | 68,275 | 65.1 K to 68.3 K (+4.92 %) |
| Aug 15 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.75 | 1,600 | 2,800 | 65,075 | 63.5 K to 65.1 K (+2.52 %) |
| Aug 15 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.74 | 300 | 522 | 63,475 | 63.2 K to 63.5 K (+0.47 %) |
| Aug 15 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.73 | 4,400 | 7,612 | 63,175 | 58.8 K to 63.2 K (+7.49 %) |
| Aug 15 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.72 | 1,900 | 3,268 | 58,775 | 56.9 K to 58.8 K (+3.34 %) |
| Aug 15 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.71 | 1,300 | 2,223 | 56,875 | 55.6 K to 56.9 K (+2.34 %) |
| Jun 05 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 2.36 | 3,000 | 7,080 | 55,575 | 52.6 K to 55.6 K (+5.71 %) |
| Jun 05 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 2.39 | 200 | 478 | 52,575 | 52.4 K to 52.6 K (+0.38 %) |
| Jun 05 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 2.33 | 1,600 | 3,728 | 52,375 | 50.8 K to 52.4 K (+3.15 %) |
| May 29 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Option Exercise | A | 2.56 | 20,000 | 51,200 | 124,500 | |
| May 18 2012 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Grant | A | 2.41 | 2,000 | 4,820 | 50,775 | 48.8 K to 50.8 K (+4.10 %) |
| Aug 17 2011 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 2.85 | 2,800 | 7,980 | 43,500 | 40.7 K to 43.5 K (+6.88 %) |
| Aug 17 2011 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 2.97 | 5,000 | 14,850 | 40,700 | 35.7 K to 40.7 K (+14.01 %) |
| Aug 17 2011 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 3.13 | 5,000 | 15,650 | 35,700 | 30.7 K to 35.7 K (+16.29 %) |
| Aug 17 2011 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 3.05 | 6,200 | 18,910 | 30,700 | 24.5 K to 30.7 K (+25.31 %) |
| Aug 22 2011 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 2.84 | 5,000 | 14,200 | 48,775 | 43.8 K to 48.8 K (+11.42 %) |
| Jun 02 2011 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Option Exercise | M | 1.15 | 10,000 | 11,500 | 94,500 | |
| Jun 02 2011 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | M | 1.15 | 10,000 | 11,500 | 24,500 | 14.5 K to 24.5 K (+68.97 %) |
| May 27 2011 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 4.99 | 500 | 2,495 | 14,500 | 14 K to 14.5 K (+3.57 %) |
| May 23 2011 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 4.96 | 1,500 | 7,440 | 14,000 | 12.5 K to 14 K (+12.00 %) |
| May 13 2011 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 4.19 | 1,000 | 4,190 | 12,500 | 11.5 K to 12.5 K (+8.70 %) |
| May 13 2011 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 4.62 | 2,500 | 11,550 | 11,500 | 9 K to 11.5 K (+27.78 %) |
| May 13 2011 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 4.88 | 2,000 | 9,760 | 9,000 | 7 K to 9 K (+28.57 %) |
| May 09 2011 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Option Exercise | A | 5.34 | 21,000 | 112,140 | 114,500 | |
| May 09 2011 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Option Exercise | A | 5.34 | 20,000 | 106,800 | 93,500 | |
| Apr 08 2011 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Option Exercise | M | 1.15 | 4,000 | 4,600 | 62,875 | |
| Apr 08 2011 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | M | 1.15 | 4,000 | 4,600 | 7,000 | 3 K to 7 K (+133.33 %) |
| Nov 18 2010 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.51 | 1,000 | 1,510 | 3,000 | 2 K to 3 K (+50.00 %) |
| Nov 18 2010 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.64 | 1,000 | 1,640 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Nov 12 2010 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Buy | P | 1.88 | 1,000 | 1,880 | 1,000 | 0 to 1,000 |
| Nov 08 2010 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Option Exercise | A | 1.77 | 35,000 | 61,950 | 35,000 | |
| Jul 30 2010 | BIOL | BIOLASE, INC | Arrow Alexander K. | Director | Option Exercise | A | 1.15 | 42,500 | 48,875 | 42,500 |
Page: 1